Home » Topics » BioWorld Science

BioWorld Science
RSS

Hinova Pharmaceuticals details compounds for cancer

Oct. 9, 2019

Pfizer identifies antibacterial agents

Oct. 9, 2019

University of California discloses new VLA-2 antagonists

Oct. 9, 2019

U.S. researchers patent ATR kinase inhibitors

Oct. 9, 2019

Faron receives DMC feedback for phase I/II MATINS trial of Clevegen

Oct. 9, 2019

GSK and Lyell Immunopharma collaborate to improve cell therapies for cancer

Oct. 9, 2019

Scenesse wins approval in U.S. for erythropoietic protoporphyria

Oct. 9, 2019

Tezepelumab reduces activation of matrix remodeling and inflammatory pathways

Oct. 9, 2019

FDA approves Wilate for hemophilia A

Oct. 9, 2019

MTPS-9579A dose-dependently inactivates airway tryptase for the treatment of asthma

Oct. 9, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...